Moleculin Biotech Inc (MBRX) Receives Average Recommendation of "Strong Buy" from Brokerages


Shares of Moleculin Biotech Inc have received a consensus broker rating score of 1.00 from the one analysts that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.



from Biotech News